Reuters logo
BRIEF-Anika Therapeutics announces regulatory approval for Monovisc® in Australia
October 16, 2017 / 8:21 PM / in a month

BRIEF-Anika Therapeutics announces regulatory approval for Monovisc® in Australia

Oct 17 (Reuters) - Anika Therapeutics Inc

* Anika announces regulatory approval for Monovisc® in Australia for the treatment of pain associated with osteoarthritis of all synovial joints

* Anika Therapeutics Inc - ‍Anika intends to further expand Monovisc into additional international markets in 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below